AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05372536 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: parent-led home-administered low-dose Cytarabine
Description: Parents to the included participants are offered to administer the protocolized low-dose bolus (injection) Cytarabine in their children's CVCs at home. The administration procedure is developed as a simple and safe non-touch technique. The parents receive a video and paper-based guideline and information material followed by a 3-step nurse-led education program. The parents can administer the Cytarabine at home when they (and the child/adolescent) feel safe and comfortable managing the procedure and when the nurses are sure that the parents can manage the procedure at home. The first dose of Cytarabine is always administered at the hospital.
Study NCT04902326 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Automated educational text messages
Description: During the first two weeks, participants receive a series of educational messages delivered via text message. These messages welcome participants to the study, set expectations for the next 12 months, and establish a general level of knowledge among all participants on prediabetes, the Diabetes Prevention Program (DPP), and metformin.~For the next 11.5 months, participants receive three automated text messages per week that provide evidence-based educational content about prediabetes and tips on prevention. Additionally, participants receive monthly messages reminding them about their health insurance plan's coverage of the DPP at no cost and coverage of metformin as a low co-pay medication, and monthly messages providing feedback on their participation in the DPP and use of metformin in the previous calendar month. Participants' PCPs receive quarterly chart updates about participation in the DPP and use of metformin, and A1c results at enrollment and 6 and 12 months.
Study NCT04902326 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Automated educational text messages
Description: During the first two weeks, participants receive a series of educational messages delivered via text message. These messages welcome participants to the study, set expectations for the next 12 months, and establish a general level of knowledge among all participants on prediabetes, the Diabetes Prevention Program (DPP), and metformin.~For the next 11.5 months, participants receive three automated text messages per week that provide evidence-based educational content about prediabetes and tips on prevention. Additionally, participants receive monthly messages reminding them about their health insurance plan's coverage of the DPP at no cost and coverage of metformin as a low co-pay medication, and monthly messages providing feedback on their participation in the DPP and use of metformin in the previous calendar month. Participants' PCPs receive quarterly chart updates about participation in the DPP and use of metformin, and A1c results at enrollment and 6 and 12 months.
Study NCT04902326 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Autonomy-supportive automated educational text messages
Description: Participants receive the same text messages as in the automated educational text message intervention, but the thrice weekly messages have been modified, where applicable, to support the participant's autonomy, in accordance with principles of Self-Determination Theory. Participants' PCPs receive quarterly chart updates about participation in the DPP and use of metformin, and A1c results at enrollment and 6 and 12 months.
Study NCT04902326 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Financial incentives
Description: Participants in this arm have the opportunity to earn a financial incentive ranging from $50 to $250 per month for taking an evidence-based action to prevent T2DM (i.e., engagement in a DPP or fill of a metformin prescription) in the previous month.
Study NCT04902326 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tailored text messages
Description: Participants receive twice-weekly tailored text messages that link evidence-based actions to prevent T2DM to the participant's self-identified top values, roles, and strengths. Text messages are also tailored, when possible, to participants' self-reported importance of taking action to try to prevent T2DM (i.e., participating in the DPP or taking metformin), confidence in being able to take such preventive action, and past preventive actions taken.
Study NCT06395103 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Zilovertamab vedotin
Description: Administered via IV infusion
Study NCT03905109 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ABX464
Description: ABX464 is a new anti-inflammatory drug. In the treatment arm, patients will receive dose A or Dose B of ABX464 orally once daily for 52 weeks.
Study NCT03905109 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: In the placebo group, patients will receive dose A or B ABX464-matching-placebo orally once daily for 52 weeks.
Study NCT05596123 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Therapeutic Chinese foot massage
Description: Participants in the TCFM group will receive six weekly 25-minute TCFM sessions by a therapist. Each session will start with an assessment of the legs and toes of the affected extremity for broken skin and lesions, which the therapist will try to avoid. The participant will be positioned with support to their foot and legs, with the sole directed downward and the therapist directly in alignment with the soles of the foot. The therapist will sequentially perform the following four steps for each TCFM session.
Study NCT05596123 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo massage
Description: The same therapist will give six weekly 25-minute placebo massage sessions to participants in the placebo massage group. These sessions will include assessing the affected extremity's legs and toes for lesions and broken skin in order to avoid them during the massage, as well as gentle foot and toe rubbing without any point stimulation or other TCFM techniques.
Study NCT05508867 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: favezelimab/pembrolizumab
Description: Coformulated favezelimab/pembrolizumab (800 mg/200 mg), IV infusion
Study NCT05508867 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: bendamustine
Description: IV infusion
Study NCT05508867 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: gemcitabine
Description: IV infusion
Study NCT06696625 — intervention group
Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: 0.1% sodium hyaluronate eye drop
Description: Participants received 0.1% sodium hyaluronate eye drop (HYLO COMOD® eye drops, Ursapharm, Ltd., Germany).
Study NCT06696625 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 0.1% sodium hyaluronate eye drop
Description: Participants received 0.1% sodium hyaluronate eye drop (HYLO COMOD® eye drops, Ursapharm, Ltd., Germany).
Study NCT05198700 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Probiotic Formulation
Description: Participants will be asked to take one sachet daily, containing 1 billion CFU of the probiotic formula. Sachets must be dissolved in warm water or mother's milk before consumption.
Study NCT05198700 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants will be asked to take one sachet containing the placebo daily. Sachets must be dissolved in warm water or mother's milk before consumption.
Study NCT03595293 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: fNIRs-based Neurofeedback
Description: Patients receive fNIRs-based neurofeedback from the rDLPFC to allow them to modify activation within this area.
Study NCT03595293 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham feedback
Description: Patients receive fNIRs-based sham feedback from the left zygomatic area to allow them to modify activation within this area.
Study NCT06697639 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Rehabilitation Group
Description: In addition to routine postpartum care, small-sized WAFF air cushions will be issued during the hospitalization period to guide patients in performing the WAFF pelvic-abdominal mechanical rehabilitation exercises. Patients will also be instructed to join the experimental group's WeChat group. After discharge, researchers will upload WAFF pelvic-abdominal mechanical rehabilitation instructional videos. Patients are required to complete their rehabilitation exercises twice daily, each session lasting 10-15 minutes. Patients need to upload their exercise videos twice a week, and researchers will provide motion guidance based on the video content until the patient's postpartum follow-up examination. The abdominal rectus muscle, pelvic floor muscle function, and adherence to rehabilitation exercises will be assessed for patients in both groups at 6-8 weeks and 6 months postpartum.
Study NCT06698016 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nemtabrutinib
Description: Oral administration
Study NCT04843852 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hepatitis B Vaccine Recombinant, Adjuvanted Intramuscular Solution [HEPLISAV-B]
Description: one 0.5ml intramuscular injection on day 0 and week 4.
Study NCT06698016 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efavirenz
Description: Oral administration
Study NCT04995796 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Surveys for Research Purposes
Description: VISIT #1:~1. Pre-Testing:~   * Pre Knowledge Test~  * Pre SURE (decisional conflict) test~2. Independent DSI/DA Interaction~3. Post-Testing:~   * Post Knowledge Test~  * Post SURE (decisional conflict) Test~  * Acceptability Index~  * Modified Single Item Literacy Screen~  * Additional Demographics~VISIT #2: Check-In Call 1 week later:~After viewing the DSI/DA and completing the post-test components above, the subjects will also complete a 5 minute debrief interview about 1 week later via phone or video conference with a team member to give feedback on their experience using the DSI/DA, including its strengths and weaknesses. This will allow for further improvement and refinement of the DSI.
Study NCT05967455 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Dengue virus 1 Live Virus Human Challenge (DENV-1-LVHC)
Description: Dengue subtype 1 Challenge Virus (DENV-1) strain 45AZ5
Study NCT05967455 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Dengue virus 3 Live Virus Human Challenge (DENV-3-LVHC)
Description: Dengue subtype 3 Challenge Virus (DENV-3) strain CH53489
Study NCT05682677 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: iTBS
Description: iTBS over the left dorsolateral prefrontal cortex
Study NCT05682677 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: sham iTBS
Description: sham iTBS over the left dorsolateral prefrontal cortex
Study NCT05682677 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Personalized, Augmented Cognitive Training (PACT)
Description: 6 sessions of PACT
Study NCT05682677 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Personalized, Augmented Cognitive Training (PACT)
Description: 6 sessions of PACT
Study NCT05956535 — intervention group
Intervention type: DEVICE
Intervention: Lotrafilcon A contact lenses
Description: CE-marked silicone hydrogel contact lenses
Study NCT05956535 — intervention group
Intervention type: DEVICE
Intervention: Balafilcon A contact lenses
Description: CE-marked silicone hydrogel contact lenses
Study NCT05900830 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: play therapy
Description: A combined program based on physical and occupational therapy techniques within a play context
Study NCT05900830 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: common educational methods
Description: the child will receive his education in a passive manner
Study NCT03287583 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: SBIRT for Gambing
Description: The SBIRT intervention uses a brief gambling screening assessment to determine whether or not a participant is at risk for problem gambling. This is followed by a structured short brief intervention to assist people in better understanding their risk for gambling and what they can do to limit that risk.
Study NCT06696976 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Telerehabilitation
Description: A qualified physiotherapist himself used the digital platform Zoom (Zoom Video Communications or WhatsApp video communication) to deliver synchronic online sessions (60 min each), sending each participant a link by email, half an hour before the weekly meetings. The patients were also invited to present themselves in comfortable gymnastic clothing and with tools useful for the motor program: a chair, a stick, a bottle full of water (or small weights if the patient had them), and a mat.~Nerve gliding exercises: These 5 Nerve gliding exercises will perform 3 times a week requiring 10 minutes to complete.~Balance exercises: Balance exercise include 10 exercises and take 20 minutes of completion, 2minute for each exercise.~Resistance training using Thera Band will performed with the presence of the researcher as an instructor.The main upper-extremity movements consisted of chest press, shoulder press etc and in lower extremity such as leg press ,back thgh press etc. in patient.
Study NCT06696976 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Clinical rehabilitation
Description: A qualified physiotherapist himself used the digital platform Zoom (Zoom Video Communications or WhatsApp video communication) to deliver synchronic online sessions (60 min each), sending each participant a link by email, half an hour before the weekly meetings. The patients were also invited to present themselves in comfortable gymnastic clothing and with tools useful for the motor program: a chair, a stick, a bottle full of water (or small weights if the patient had them), and a mat.~Nerve gliding exercises: These 5 Nerve gliding exercises will perform 3 times a week requiring 10 minutes to complete.~Balance exercises: Balance exercise include 10 exercises and take 20 minutes of completion, 2minute for each exercise.~Resistance training using Thera Band will performed with the presence of the researcher as an instructor.The main upper-extremity movements consisted of chest press, shoulder press etc and in lower extremity such as leg press ,back thgh press etc. in patient.
Study NCT06697587 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Enhanced Cognitive Reappraisal and Emotion Awareness Training (eCREAT)
Description: eCREAT features psychoeducational content on anger management, practical exercises, and homework assignments, all supported by an online therapist who provides text-based feedback. The protocol builds on a previously evaluated protocol for maladaptive anger (ClinicalTrials.gov; ID: NCT03858296) with added focus on anger inhibition.~eCREAT is based on the two-stage model of maladaptive anger inhibition (Burns et al., 2008), which posits that suppressed anger may rebound and return as angry fantasies and ruminations. To address these core mechanisms, the treatment includes training on adaptive anger processing and expression and strategies for disrupting anger ruminations. These added treatment components are based on established protocols for depressive rumination, and assertive expression of emotion, adapted for an anger context. Additionally, the treatment also focuses on how to flexibly shift between different emotion regulation strategies depending on contextual demands.
Study NCT06698120 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Awake prone positioning (APP)
Description: * APP are realized following the diagnosis of ACS~* Prone positioning or supine positioning are performed under supervision of a physician or a nurse~* Maximum session duration: 16 hours per day~* Sessions of prone positioning can be shortened, if necessary (30 minutes minimum), for better tolerance~* Tolerance of prone positioning is assessed by the physician in charge and sessions and may be stopped in case of poor tolerance
Study NCT03287583 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Enhanced Control
Description: Participants randomized to the enhanced control condition will receive a handout with gambling resources.
Study NCT06696586 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fentanyl infusion
Description: will received lidocaine with dose 250 mg and fentanyl infusion in dose of 200 µg in rate 10ml /hr using 50ml syringe pump.
Study NCT06696586 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fentanyl Injection
Description: will receive lidocaine 250 mg in addition to fentanyl injection in dose 100 µg by shots
Study NCT05931588 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pilates excercises, streching and breathing
Description: international group receive Pilates exercises, stretching and breathing two times a week (30 min per session) perform 3 to 5 reps of Pilates exercises under supervision
Study NCT05931588 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: stretching and breathing
Description: control group guided with stretching and breathing home based program both group till 8 week both groups
Study NCT05128773 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amcenestrant
Description: tablet, oral
Study NCT05128773 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tamoxifen
Description: tablet, oral
Study NCT05128773 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Amcenestrant-matching placebo
Description: tablet, oral
Study NCT05128773 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tamoxifen-matching placebo
Description: tablet, oral
Study NCT06364696 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ASP4396
Description: Intravenous (IV) infusion
Study NCT05521724 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: exercise
Description: resistance and strengthening exercises will be applied to a randomized patient group.
Study NCT05521724 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: exercise
Description: resistance and strengthening exercises will be applied to a randomized patient group.
Study NCT06403111 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Fecal Microbiota Transplantation (FMT)+chemotherapy+immunotherapy
Description: Participants will receive FMT combined with tislelizumab + pemetrexed + platinum-based treatment (lung adenocarcinoma) / albumin-bound paclitaxel + platinum-based treatment (lung squamous cell carcinoma) for 4-6 cycles. If there is no progression of the disease after 4-6 cycles of the first-line treatment, then patients will enter the maintenance treatment stage. Patients will receive tislelizumab maintenance treatment (lung squamous cell carcinoma), or tislelizumab + pemetrexed maintenance treatment (lung adenocarcinoma).
Study NCT04935437 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Supervised rehabilitation program.
Description: The program includes aerobic exercise, strengthening exercises, physiotherapy, psychological support and dietary advice.
Study NCT06697275 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Hypnotic Virtual reality
Description: Hypnotic Virtual reality mask Deepsen® with age-appropriate software Birdy®
Study NCT06697275 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Interactive virtual reality
Description: Interactive virtual reality mask Deepsen® with age-appropriate software Birdy®
Study NCT06697275 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard method
Description: Use of local anesthesic cream + Nurse and/or parents distraction +/- anxioloytic gas
Study NCT06698159 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Cryoablation with cryoballoon 28 mm
Description: Pulmonary vein isolation using 28 mm balloon cryoablation
Study NCT06698159 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Cryoablation with cryoballoon 31 mm
Description: Pulmonary vein isolation using 31 mm balloon cryoablation
Study NCT06697834 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Histotripsy ultrasound session
Description: The study will be performed with the MINDRAY DP-10 ultrasound device equipped with a linear probe and histotripsy functionality.
Study NCT06697834 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: VAS questionnaire
Description: Pain assessment with the EVA questionnaire
Study NCT06697834 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: AOFAS questionnaire
Description: AOFAS questionnaire at visit 1 and visit 4 (75 days after the first visit).
Study NCT04811651 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Umbilical Cord-derived Mesenchymal Stem Cells
Description: umbilical cord derived mesenchymal stem cells were intravenously injected in a single dose of one hundred million.
Study NCT04811651 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: intravenous placebo solution with the same appearance as the treatment group.
Study NCT03104569 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Injection of 37℃ contrast agent
Description: Nonionic contrast agent is heated to 37℃ in a incubator when injection of contrast agent
Study NCT04880876 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 25mg Eluxadoline
Description: Oral Tablets
Study NCT04880876 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 100mg Eluxadoline
Description: Oral Tablets
Study NCT05552157 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Remternetug (SC)
Description: Administered subcutaneously every 12 weeks
Study NCT05552157 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Remternetug (SC)
Description: Administered subcutaneously every 12 weeks
Study NCT06447441 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Enteral supplementation of placebo in 3 consecutive days within 96 hours after ICU admission.